Analysts think CERS stock price could increase by 255%
Jun 05, 2025, 11:25 AM
7.32%
What does CERS do
Cerus, headquartered in Concord, California, focuses on developing the INTERCEPT Blood System to enhance blood safety by reducing pathogens in transfusion blood components. The company employs 288 people and specializes in various blood products.
5 analysts think CERS stock price will increase by 255.40%. The current median analyst target is $5.10 compared to a current stock price of $1.44. The lowest analysts target is $4.04 and the highest analyst target is $5.25.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.